Insider Transactions in Q2 2021 at Travere Therapeutics, Inc. (TVTX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,780
-3.14%
|
$66,920
$14.35 P/Share
|
|
Jun 01
2021
|
Eric M Dube CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,782
-3.05%
|
$66,948
$14.89 P/Share
|
|
May 14
2021
|
Ron Squarer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+16.78%
|
-
|
|
May 14
2021
|
Sandra Poole |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+24.0%
|
-
|
|
May 14
2021
|
John A Orwin |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+16.78%
|
-
|
|
May 14
2021
|
Jeffrey A Meckler |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+4.29%
|
-
|
|
May 14
2021
|
Steve Aselage Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.56%
|
-
|
|
May 14
2021
|
Gary A Lyons |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+7.5%
|
-
|
|
May 14
2021
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+15.0%
|
-
|
|
May 14
2021
|
Suzanne Louise Bruhn |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+26.67%
|
-
|
|
May 14
2021
|
Timothy Coughlin |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+7.89%
|
-
|
|
May 12
2021
|
Laura Clague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-6.62%
|
$38,000
$19.46 P/Share
|
|
May 12
2021
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
1,625
-4.5%
|
$30,875
$19.46 P/Share
|
|
May 12
2021
|
Noah L. Rosenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
375
-0.82%
|
$7,125
$19.46 P/Share
|
|
May 12
2021
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
1,562
-4.7%
|
$29,678
$19.46 P/Share
|
|
May 11
2021
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
2,146
-1.14%
|
$40,774
$19.58 P/Share
|
|
May 11
2021
|
Laura Clague Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-6.21%
|
$38,000
$19.14 P/Share
|
|
May 11
2021
|
Elizabeth E Reed SVP, GC & CORPORATE SECRETARY |
SELL
Open market or private sale
|
Direct |
1,625
-4.31%
|
$30,875
$19.14 P/Share
|
|
May 11
2021
|
Noah L. Rosenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
375
-0.81%
|
$7,125
$19.14 P/Share
|
|
May 11
2021
|
William E. Rote SENIOR VICE PRESIDENT, R&D |
SELL
Open market or private sale
|
Direct |
1,563
-4.49%
|
$29,697
$19.14 P/Share
|
|
Apr 16
2021
|
Steve Aselage Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.03%
|
$260,000
$26.23 P/Share
|
|
Apr 16
2021
|
Steve Aselage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.79%
|
$160,000
$16.23 P/Share
|